Moleculin Biotech is trading 6.41% up at $0.41, supported by a broader biotech rally, with XBI up 2.09% during regular trading.
- The stock remains volatile after its $9.3 million public offering closed August 3.
- The offering involved 12,376,667 shares and warrants for up to 37,130,001 additional shares at $0.75, creating continued dilution and selling-pressure concerns.